Kiniksa Pharmaceuticals International KNSA
NASDAQ KNSA
$75.89 +0.67 (+0.89%)
As of: Oct 2, 2026 · 2:11 PM EDT

Kiniksa Pharmaceuticals International (KNSA) Net Equity Issued and Repurchased (2018 - 2026)

Updated

Kiniksa Pharmaceuticals International (KNSA) reported Net Equity Issued and Repurchased of $17.58 million for Q2 2026, up 37.9% from $12.75 million a year earlier and up 175.1% from the prior quarter.

Analysis

Kiniksa Pharmaceuticals International (KNSA) Net Equity Issued and Repurchased (2018 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Kiniksa Pharmaceuticals International's Net Equity Issued and Repurchased came in at $48.8 million, up 74.0% year-over-year; for FY2025, it came in at $40.75 million, up 136.2% from FY2024.

  • Net Equity Issued and Repurchased has increased for three consecutive years, with a five-year compound annual growth rate of 44.1% (FY2020 to FY2025).
  • By year, Net Equity Issued and Repurchased came in at $17.25 million in FY2024 (+366.1%), $3.7 million in FY2023 (+8.3%), $3.42 million in FY2022 (-41.9%) and $5.89 million in FY2021 (-10.2%).
  • The Q2 2026 figure ranks as the highest quarterly Net Equity Issued and Repurchased since Q3 2020.
  • Year over year, Net Equity Issued and Repurchased has now increased in each of the last four quarters, with growth averaging 151.2% over the last seven quarters.
  • The high point for year-over-year Net Equity Issued and Repurchased in five years was Q1 2024 (growth of 683.1%); the low point was Q3 2021 (a decline of 97.7%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $6.39 million (Q1 2026), $8.58 million (Q4 2025) and $16.25 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 43.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 6.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 9.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 47.70 Mn
10 Kiniksa Pharmaceuticals International 11.64 Bn 10.38 Bn 220.03 Mn 17.58 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 17.58 Mn
Mar 31, 2026 6.39 Mn
Dec 31, 2025 8.58 Mn
Sep 30, 2025 16.25 Mn
Jun 30, 2025 12.75 Mn
Mar 31, 2025 3.18 Mn
Dec 31, 2024 2.72 Mn
Sep 30, 2024 9.40 Mn
Jun 30, 2024 1.14 Mn
Mar 31, 2024 3.99 Mn
Dec 31, 2023 957,000.00
Sep 30, 2023 1.66 Mn
Jun 30, 2023 577,000.00
Mar 31, 2023 510,000.00
Dec 31, 2022 1.29 Mn
Sep 30, 2022 569,000.00
Jun 30, 2022 566,000.00
Mar 31, 2022 992,000.00
Dec 31, 2021 1.21 Mn
Sep 30, 2021 2.68 Mn
API Access

Kiniksa Pharmaceuticals International Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=KNSA&period=max&api_key=YOUR_API_KEY